Kathleen D. Scott Silverback Therapeutics, Inc. (SBTX) insider trading activity

SBTX Quotes by TradingView

Kathleen D. Scott Transaction History

Date Transaction Value Shares Traded Form
Nov 29 2022
BUY
Open market or private purchase
$51,480 $6.24 p/Share
8,250

Also insider at

DRMA
Dermata Therapeutics, Inc. Healthcare
GFOR-WT
Graf Acquisition Corp. IV
Director
KDS

Kathleen D. Scott

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on SBTX

Follow Silverback Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SBTX shares.

Notify only if

Insider Trading

Get notified when an Silverback Therapeutics, Inc. insider buys or sells SBTX shares.

Notify only if

News

Receive news related to Silverback Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SBTX